Xenon Pharmaceuticals submits filing for lead drug candidate
Xenon Pharmaceuticals said it submitted a regulatory filing for its lead drug candidate, bringing it closer to its first commercial product, though the update was overshadowed by a clinical setback.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.